This is the real cost of a slow or uncertain cleaning validation programme. Not the cost of the instrument. Not the complexity of the method. The cost is measured in hours of lost production, delayed releases and the quiet anxiety of knowing that if an inspector walked in right now, your data trail would not tell a clear and convincing story.

Total organic carbon (TOC) analysis exists precisely to eliminate that anxiety. When implemented correctly, it is one of the fastest, most regulator-friendly, and most operationally practical cleaning verification methods available. This article explains why so many labs are not using it that way and what it takes to change that.

What does a failed clean actually cost?

Most cleaning validation conversations start with the method. They should start with the consequence. A single failed clean in a pharmaceutical or food manufacturing facility does not just mean re-cleaning the vessel. It means halting production, quarantining potentially affected batches, initiating a deviation investigation, documenting the root cause, re-validating the cleaning cycle and demonstrating to QA that it will not happen again. In a worst-case scenario, that is days of downtime on a critical piece of manufacturing equipment.

The Chemetrix team has seen this play out in facilities relying on product-specific methods like HPLC for cleaning verification. When an unknown degradant or cleaning agent residue slips through undetected, the specific method offers no warning. TOC does. Because it measures the total organic carbon in a rinse or swab sample, it catches APIs, degradants, excipients and cleaning agents in a single analysis. There is no invisible contamination with a properly implemented TOC method.

This matters enormously in a regulated environment because it removes operator subjectivity from the result. There is no peak integration to argue about, no ghost peaks to investigate and no ambiguity about whether a signal is real or an artefact. The FDA has issued numerous warning letters specifically for HPLC data integrity failures, including failure to integrate peaks and inadequate investigation of unknown peaks. These problems are structurally unavoidable in product-specific methods because cleaning processes generate degradants and unexpected compounds that the specific method was never designed to detect.

The short answer is yes – in most cases, TOC is more cost-effective than HPLC, often delivering noticeable savings within the first year of implementation.

Chemetrix Insight: “TOC almost always reduces total validation costs within the first year by accelerating batch release and reducing the frequency of re-testing. The instrument cost is recovered faster than most labs expect.”

When TOC results are inconsistent or a cleaning validation programme is not delivering the confidence it should, the problem is almost never the analyser. Here is the hierarchy of where to look first.

What makes the Veolia Sievers M9 the right instrument for pharmaceutical cleaning validation?

The pace of scientific discovery is no longer governed solely by the physical limits of manual experimentation. We are currently witnessing a shift that is as transformative as the invention of the microscope itself. Artificial Intelligence (AI) and advanced metabolomics are reshaping how science is conducted, moving research from a “trial-and-error” model to a predictive, data-driven discipline. By combining high-resolution analytical hardware with machine learning, laboratories can now solve complex biological challenges – such as developing animal-free culture media – with unprecedented speed.

The complexity of the modern workflow

In the fast-evolving landscape of biopharmaceuticals and cell biology, the reliance on traditional methods often leads to significant hurdles. For decades, the industry has relied on fetal bovine serum (FBS) to supplement cell culture media, despite its high costs, ethical concerns, and inherent inconsistency.

Many lab teams find themselves buried under mountains of raw data from complex matrices, struggling to identify which specific molecular components actually drive performance.

When dealing with undefined raw ingredients, such as plant and microbial extracts, understanding chemical composition is critical to ensuring batch-to-batch reproducibility and process continuity when scaling.

From raw peaks to actionable insights

The challenge in modern labs isn’t a lack of data; it is the complexity of interpreting high-dimensional datasets. Manual analysis of thousands of formulations is no longer feasible. As regulatory requirements for biologics become more stringent, the demand for defined, reproducible, and regulatory-compliant media has grown.

Advanced metabolomics provides the molecular profiling required to qualify raw materials, while AI handles the broad combinatorial screening. This synergy allows researchers to tailor media composition to specific cell lines, improving yield and efficiency across the drug development lifecycle.

At Chemetrix, we have been an authorised Agilent distributor in Southern and East Africa for decades. While our heritage is diverse, our commitment to the pharmaceutical sector is foundational. We don’t just supply instruments; we provide the technical scaffolding that allows pharmaceutical analysts to move from a raw sample to a validated report with total confidence.

Why great hardware isn’t enough

One of the most persistent challenges in the pharmaceutical workflow is the transition from a concept to a robust, validated method. It is a common misconception that high-end instrumentation automatically guarantees ease of use. In reality, pharmaceutical analysts often struggle with the “blank space” between unboxing an instrument and running their first compliant sample.

Whether you are identifying trace impurities, performing stability testing, or conducting complex bioanalysis, the method development phase is often where projects stall. A method that works in a controlled environment can fail in a high-throughput production setting if it hasn’t been stress-tested for robustness. This leads to a reactive cycle of troubleshooting and re-validation, which drains resources and delays time-to-market.

Navigating a shifting regulatory landscape

Data integrity is the non-negotiable cornerstone of the pharmaceutical industry. Global research shows that 90% of pharmaceutical professionals agree that reliable instruments are the single most important factor for a successful workflow. This is because, in this sector, a failure in reliability is a failure in compliance.

The pressure to process more samples while maintaining absolute adherence to 21 CFR Part 11 and EudraLex Annex 11 is immense. Without a partner who understands the nuances of IQ/OQ (Installation and Operational Qualification) and ongoing maintenance, labs risk falling into the “efficiency gap.” This is where sophisticated instruments sit underutilised because the method is too temperamental or the staff lack the specific training required to navigate the software’s compliance features.

Mastery of complex matrices with Agilent LC/MS

For laboratories tackling the most demanding pharmaceutical applications – such as nitrosamine analysis or impurity profiling– Agilent’s LC/MS solutions are globally recognised as the definitive standard. These systems provide the sensitivity and specificity required to detect analytes at levels that were previously unimaginable.

However, the “Chemetrix Edge” lies in how we support this technology. We recognise that method development for LC/MS is a specialised skill. Our support department acts as an extension of your own team, providing on-site assistance to help you develop, optimise, and troubleshoot your pharmaceutical methods. By leveraging our local application expertise, you can reduce the time spent in method development and ensure that your LC/MS system is performing at its peak from day one.

Chemetrix supports this hardware through a comprehensive service programme that goes beyond simple repairs. We offer tailored preventive maintenance and rapid-response technical support to ensure your 1290 Infinity III stays in a qualified state. By integrating our service expertise with this robust hardware, we help labs eliminate the “time traps” of manual intervention. Our goal is to ensure your staff spend less time worrying about baseline
drift and more time focusing on high-value data interpretation.

The reward of proactive support

The transition from a reactive laboratory to a proactive one is transformative. When you partner with a specialist who understands pharmaceutical applications, the results are measured in more than just uptime. You gain the peace of mind that comes from knowing your methods are robust, your instruments are qualified, and your data is defensible.

Our most successful pharmaceutical partners are those who have moved away from viewing instrumentation as a commodity and have embraced it as a collaborative workflow. This partnership leads to faster validation cycles, fewer “Out of Specification” (OOS) investigations, and a laboratory team that is empowered by their technology rather than frustrated by it.

 

If this sounds familiar, you aren’t alone. Modern laboratories are no longer just places of discovery; they are high-pressure environments where efficiency, accuracy, and cost-control must live in perfect harmony. But how do you scale your output without scaling your stress levels?

The growing pains of the modern lab

The challenges facing today’s lab managers are multifaceted. According to global research by Agilent, a staggering 45% of lab managers face significant pressure to process more samples, yet they are expected to do so without increasing operational costs.

Beyond volume, there is the hurdle of unplanned downtime. Around 75% of lab managers cite instrument maintenance and downtime as their biggest headache. In the pharmaceutical sector, this figure rises even higher, where 90% of professionals agree that reliable instruments are the single most important factor for a successful workflow. Add to this the physical constraints of small laboratory premises and the constant evolution of regulatory standards, and it is easy to see why many feel they are running to stand still.

Navigating the efficiency trap

When we talk about “lab efficiency,” we often think of speed. However, true efficiency is about data integrity and resource management. Many laboratories still rely on manual processes that are prone to human error, leading to costly re-tests.

Data shows that in many traditional setups, some lab instruments are only being utilised 35% of the time, while the rest of the day is lost to manual sample preparation, cleaning, or waiting for repairs.

Automating the mundane with Chemetrix

One of the most effective ways to reclaim your time is through Lab Automation. Chemetrix positions itself as more than a supplier; we are a partner in your workflow. By identifying “time traps” in your daily routine – such as repetitive liquid handling or manual SPE (Solid Phase Extraction) – we can help you transition to a smarter way of working.

A standout solution in this space is the Agilent 1260 Infinity III LC System. This instrument is a workhorse designed for the “everyday” challenges of a busy lab. It allows you to mix and match modules with existing setups, meaning you don’t have to overhaul your entire lab to see an immediate boost in throughput. Chemetrix assists by providing the technical expertise to integrate these systems seamlessly, ensuring your staff are trained to focus on high-value data interpretation rather than the repetitive motion of pipetting.

Smarter analysis with the 8890 gas chromatograph

Maintenance shouldn’t be a game of “wait and see.” To combat the 75% of downtime caused by maintenance issues, Chemetrix recommends moving toward Instrument Intelligence.

When you partner with Chemetrix, you gain access to our “Support When You Need It” guarantee. Our experts don’t just deliver a box; we help you configure the 8890 to your specific applications – whether that’s environmental testing or complex chemical analysis – ensuring maximum uptime and a much higher return on investment.

From pressure to productivity: The power of partnership

The ultimate goal of any laboratory is to produce results that make a difference. When you move from a reactive “fix-it” mindset to a proactive, automated workflow, the results are transformative.

Imagine a lab where instruments “hum” along without intervention, where data integrity is guaranteed by digitisation, and where your team has the breathing room to innovate. This isn’t a futuristic dream; it is the reality for laboratories that have embraced smarter technology. By reducing manual intervention, you not only increase your sample capacity but also improve the morale of your team, allowing them to do the science they were actually trained for.

Take the first step towards a smarter lab

You don’t have to solve every challenge at once. Improving lab efficiency is a journey, and it starts with a single conversation. Whether you’re struggling with limited bench space, rising costs, or frustrating downtime, the team at Chemetrix is ready to listen.

Your next move: Why not audit your current workflow? Identify your biggest “time trap” and contact a Chemetrix expert today for a tailored consultation. Let’s work together to turn your laboratory challenges into your greatest competitive advantage.

Visit our website to explore our full range of analytical solutions or join one of our upcoming webinars to learn how to free your workflow from common time traps.

The mystery of the rising “Blanks”

If you’ve ever sat in front of your workstation wondering why your Blank and Background Equivalent Concentration (BEC) values are stubbornly high, you aren’t alone. It is a common frustration for geochemical analysts: your instrument is calibrated, your reagents are fresh, yet the background noise refuses to quieten down. These elevated values aren’t just technical nuisances; they directly impair your Limit of Quantification (LOQ). In a world where a $0.1\text{ g/t}$ difference in a gold tailings project can determine financial success, “noisy” data is a risk you cannot afford to take.

Understanding the noise: BEC and LOQ

To solve the problem, we first have to understand it. The BEC represents the total background signal of your analytical system – essentially the “noise” the instrument sees when no sample is present. When this noise is high, your instrument struggles to distinguish a genuine analyte signal from the background. This directly pushes up your LOQ, making it impossible to accurately quantify the lower concentrations that modern mining exploration demands. The root cause of these high values? It usually comes down to one single, persistent word: CONTAMINATION.

Clean up your act with expert training and standards

If your sample preparation isn’t meticulous, even the most advanced mass spectrometer will produce compromised results. Contamination is a silent thief that enters your workflow through water purity, reagent quality, and even the laboratory personnel themselves – common culprits include cosmetics, jewellery, and the powder in traditional gloves.

The Chemetrix Edge: We don’t just supply tools; we build expertise. Through the Chemetrix Lab Advisor, we provide your team with the specialised skills needed to identify and eliminate these “time traps”. By pairing this training with high-purity Inorganic Ventures Certified Reference Materials (CRMs), you ensure your calibration is built on a foundation of absolute purity.

Practical advice:

• Stop the “Double-dip”: Never pipette directly from the stock bottle; transfer your working volumes into clean, secondary containers like pre-rinsed LDPE bottles.
• Go gravimetric: Switch to weight-based (gravimetric) preparation. Mass doesn’t change with temperature, whereas volume does, leading to more reproducible and auditable results.

Technology that does the heavy lifting

While a clean bench is vital, the right hardware can act as your final line of defence against complex mineral matrices. Mining ores are notorious for their high levels of dissolved solids, which traditionally require extensive manual dilution – a process that introduces even more opportunities for human error and contamination.

The Chemetrix Edge: We recommend the Agilent 7850 / 7900 / 8900 ICP-MS series as the physical solution to these high-matrix challenges. These instruments are equipped with Ultra High Matrix Introduction (UHMI) technology, which uses clean Argon gas to “dilute” your sample aerosol before it even reaches the plasma.

Practical advice:

By using the Agilent 7850’s UHMI system, your lab can directly analyse samples containing up to $25\%$ total dissolved solids without manual liquid dilution. This not only saves hours of labour but practically eliminates the risk of dilution errors and reagent-born contamination.

From waste to wealth: The reward of precision

The ultimate goal of refining your workflow is simple: lower LOQs and higher confidence. When you master your contamination control, you unlock the ability to see value where others see waste. Successful tailings reclamation depends on this precision. By accurately monitoring recovery at trace levels, mining operations can turn legacy liabilities into profitable resources, contributing to a more sustainable and circular mining economy.

Take the next step towards cleaner data

Ready to lower your detection limits and boost your lab’s productivity? It starts with a partnership that understands your specific challenges.

Review your prep: Identify one source of potential contamination today (check those gloves!)

Audit your standards: Ensure your CRMs are matrix-matched to your ores for better accuracy.

Connect with Chemetrix: Let our team of scientists help you tailor a solution that combines Agilent’s world-class technology with practical, on-the-ground support.

Let’s advance science together. Contact Chemetrix today to explore how we can elevate your laboratory’s performance.

]]> https://chemetrix.co.za/from-dust-to-diamonds-how-to-master-trace-metal-analysis-in-modern-mining/feed/ 0 https://chemetrix.co.za/are-your-drug-tests-predicting-clinical-reality/ https://chemetrix.co.za/are-your-drug-tests-predicting-clinical-reality/#respond Mon, 19 Jan 2026 08:00:17 +0000 https://chemetrix.co.za/?p=7231 Continue reading "Are Your Drug Tests Predicting Clinical Reality?"]]> A promising drug candidate passes every 2D cell culture test. The data looks perfect. Then it fails in clinical trials because it behaves completely differently in actual human tissue. This scenario plays out in pharmaceutical labs every day. The problem isn’t the science or the scientists. It’s the fundamental limitation of using 2D cell models to determine drug efficacy and toxicity when those models don’t adequately address the complexity of real world 3D tissues.

When 2D models stop being enough

Why 3D samples provide more useful data

Biologically relevant 3D cell models provide more useful data than traditional 2D cultures. But why does dimension matter so much?

Ex vivo models help researchers gain insight into a drug’s mechanism of action and safety within a more physiologically relevant context than cell cultures. When you test a drug on cells growing flat on plastic, you’re studying biology that doesn’t exist in patients. When you test the same drug in ex vivo samples like clinical biopsies or tumouroids, you’re studying biology that actually resembles the tissue the drug will encounter.

3D samples like tumouroids and ex vivo clinical biopsies are more biologically relevant than traditional 2D cell assays because they retain structural complexity, cell-to-cell interactions and tissue architecture that influence how drugs actually work. A compound that appears effective in a monolayer might fail to penetrate a 3D structure. A drug that seems safe in 2D might trigger unexpected responses when cells interact in three dimensions.This isn’t just about making experiments more complicated. It’s about making data more predictive. The goal of drug development is to understand how compounds will behave in patients. Ex vivo systems move researchers closer to that reality. The challenge has been measuring these complex samples reliably. That’s where tool selection becomes critical.

Making ex vivo workflows work

24-well metabolic analyzer, Seahorse XF Flex Analyzer | Agilent

Practical applications:

Confocal High Content Imaging Microscope, BioTek Cytation C10 | Agilent

There’s a common mindset in drug discovery that researchers must accept the limitations of 2D models because ex vivo systems are too difficult. That working with clinical biopsies isn’t practical. That 3D cultures are too complex for routine use.

Chemetrix rejects this narrative.Researchers shouldn’t settle for models that don’t adequately address the complexity of real world 3D tissues. They shouldn’t compromise scientific rigour because tools weren’t designed for physiologically relevant samples. And they absolutely shouldn’t accept that predicting clinical outcomes requires choosing between feasibility and accuracy.

This is where partnership matters. Chemetrix doesn’t just supply instruments. We advocate for a scientific culture grounded in integrity, accuracy and respect for the complexity of living systems. When we say ex vivo models provide more useful data, we’re affirming that good science requires data that reflect real biology. The lack of tools for cellular phenotyping of ex vivo samples has been a barrier for too long. The Seahorse XF Flex and Cytation C10 aren’t just instruments. They’re commitments to removing barriers between researchers and the capabilities they need.

Chemetrix partners with researchers because they deserve solutions designed with biological reality in mind. Ex vivo systems that work reliably. Analysis that captures what matters. Support that helps labs implement physiologically relevant models confidently. This is how drug development advances: not through researchers heroically overcoming inadequate tools, but through systems that make biological relevance routine.

Drug development doesn’t have to rely on models that don’t adequately address the complexity of real world 3D tissues. Biologically relevant 3D cell models provide more useful data. But only when you have tools designed for cellular phenotyping of ex vivo samples.

Ready to move beyond 2D limitations?

✅ TL;DR – Key Takeaways

• Using 2D cell models to determine drug efficacy and toxicity does not adequately address the complexity of real world 3D tissues
• Ex vivo models help researchers gain insight into drug mechanism of action and safety within a more physiologically relevant context than cell cultures
• 3D samples like tumouroids and ex vivo clinical biopsies are more biologically relevant than traditional 2D cell assays
• The Seahorse XF Flex and Cytation C10 address the lack of tools for cellular phenotyping of ex vivo samples

Here’s what most food testing labs don’t realise: the perceived complexity of coupling HPLC to ICP-MS is largely a myth. With the right hardware and software integration, what seems like a daunting technical challenge becomes a routine workflow that delivers results in under two minutes per sample.

Why toxic element speciation matters

Not all arsenic is created equal. Total arsenic measurements tell you how much is present, but they don’t tell you the critical part: is it toxic? Inorganic arsenic (the sum of arsenite As(III) and arsenate As(V)) is significantly more toxic than organic arsenic compounds like arsenobetaine found naturally in seafood. This is why regulations specify limits for inorganic arsenic rather than total arsenic. A rice cereal might contain arsenic, but if it’s all organic forms, the health risk is minimal. If it’s inorganic arsenic, even at low concentrations, it poses a developmental risk
to infants.

The same principle applies to other toxic elements. Cadmium accumulates in rice grown in contaminated soil. Lead and mercury, even at trace levels, affect neurological development in children. The US House of Representatives report in February 2021 found that many baby foods sold in supermarkets contained unacceptably high concentrations of these elements.

This is where speciation analysis becomes critical. HPLC separates different chemical forms of arsenic before ICP-MS detects them. By oxidising As(III) to As(V) during sample preparation, the analysis simplifies to measuring one peak representing total inorganic arsenic. The chromatographic separation happens in under two minutes, the ICP-MS provides sensitivity down to parts per billion and labs can confidently determine whether a food product meets regulatory limits.Food testing labs aren’t just generating data. They’re protecting the most vulnerable consumers: babies, infants and young children whose developing bodies are most susceptible to toxic element exposure.

Image credit: Institut für Analytische Chemie Universität Wien

The integration that changes everything

The breakthrough isn’t in the HPLC or the ICP-MS individually. Both instruments are well known in the industry for performance and robustness. The efficiency gain comes from how they work together. Agilent developed an optimised interface that physically couples the Agilent 1260 Inifinity III HPLC to both the 8900 ICP-QQQ and 7850 ICP-MS systems. But the real innovation is software integration. The entire coupled system is set up and operated from the ICP-MS MassHunter software. One interface. One method. Automated analysis.

Single software control means analysts don’t toggle between platforms or manually synchronise instrument parameters. Method development happens in one place.

Stable hardware coupling removes the guesswork from connecting instruments. The optimised interface ensures consistent sample transfer without leaks, dead volume or carryover issues.

Reduced setup time transforms HPLC-ICP-MS from a specialist technique into a routine capability. Labs new to speciation analysis can implement the method without extensive troubleshooting.

Fast 2-minute runs change the economics of compliance testing. When analysing inorganic arsenic requires 10+ minutes per sample using conventional columns, labs face real capacity constraints. At 2 minutes per sample, the same instrument processes five times the volume.

The 7850 ICP-MS adds practical features that matter for real-world food matrices. Ultra High Matrix Introduction (UHMI) handles samples with high dissolved solids without constant maintenance. The IntelliQuant function provides instant visibility into total matrix composition. And helium collision mode addresses spectral interferences without complex method optimisation.

Food safety compliance made routine

The US Baby Food Safety Act 2021 proposes maximum levels of 10-15 ppb inorganic arsenic depending on whether products are cereal-based. The FDA’s Closer to Zero plan phases in action levels for lead, arsenic, cadmium and mercury through 2024 and beyond. EU regulations specify limits for inorganic arsenic in rice between 0.1-0.3 mg/kg.

These aren’t aspirational targets. They’re enforceable limits that require labs to deliver accurate, defensible results.

The Agilent 1260 HPLC coupled to the Agilent 8900 ICP-QQQ provides the sensitivity and speed food testing labs need. The 8900 offers detection limits of 1.99 µg/kg for solid samples and 0.08 µg/L for liquid samples, well below regulatory action levels. The method complies with FDA Elemental Analysis Manual sections 4.7 and 4.11, as well as European standards EN16802:2016 and prEN17374:2019.

Real-world validation across baby foods, rice cereals, beverages and animal feed demonstrates recoveries between 82-111% with precision from 0.3-9.4% RSD.

📚 LEARN MORE: Application Note: Analysis of Inorganic Arsenic, Cadmium, Lead and Mercury in Baby Foods by ICP-MS (5994-3713EN)

Agilent 1260 Infinity III LC System

Agilent 7850 ICP-MS

High-throughput screening for production environments

Food manufacturers testing ingredients before use or finished products before release face a different challenge. They need screening capability that keeps pace with production schedules. Samples can’t wait days for results. Backlogs mean inventory sitting in quarantine.

The Agilent 1260 HPLC coupled to the Agilent 7850 ICP-MS delivers the throughput production labs require. The 7850 combines proven hardware with software features that simplify workflow for analysts who may be new to ICP-MS or new to Agilent systems. The 7850’s 10 orders of magnitude linear dynamic range means major and trace analytes are measured in a single run. No over-range failures. No sample reruns. The system processes samples with per cent-level total dissolved solids thanks to UHMI technology as standard.

For inorganic arsenic screening in rice cereals, the fast HPLC-ICP-MS method reduces analysis time from over 10 minutes to under 2 minutes. The short anion exchange column, optimised mobile phase and small injection volumes maintain baseline separation of inorganic arsenic from organic species without compromising resolution.

📚 LEARN MORE: Application Note: Fast Determination of Inorganic Arsenic in Food and Animal Feed by HPLC-ICP-MS (5994-1642EN)

There’s a pervasive mindset in many labs that complexity is just part of the job. That coupling instruments will always be difficult. That fast methods sacrifice accuracy. That meeting new regulatory limits requires hiring specialists or sending samples to reference labs.

Chemetrix rejects this narrative. Labs shouldn’t have to choose between speed and accuracy. They shouldn’t accept that advanced techniques are only accessible to experts. And they absolutely shouldn’t operate under the assumption that their current capabilities define their future possibilities.

This is where partnership matters. Chemetrix doesn’t just supply instruments. We advocate for a scientific culture grounded in integrity, accuracy and respect for the people doing the work. When we say the Agilent HPLC-ICP-MS coupling is easier than labs think, we’re not minimising the science. We’re affirming that with the right tools and support, routine labs can deliver extraordinary results.

The optimised interface, integrated software control and proven application methods aren’t just technical specifications. They’re a commitment to removing barriers between labs and the capabilities they need.

Conclusion

Toxic element analysis in food doesn’t have to be the bottleneck in your lab. The perceived complexity of HPLC-ICP-MS coupling dissolves when hardware and software are designed to work together from the start.

Ready to transform your toxic element analysis workflow?

Download the application notes for baby food and rice cereal analysis to see validated methods and real-world results. Contact Chemetrix to discuss how fast HPLC-ICP-MS screening can eliminate testing bottlenecks in your facility.

Food safety depends on labs that can deliver accurate results quickly. With the right partnership and the right tools, your lab can be exactly that kind of asset.

Contact Chemetrix today to discuss your toxic element analysis challenges and discover solutions designed for your reality.

✅ TL;DR – Key Takeaways

• HPLC-ICP-MS coupling is simpler than most labs assume when using integrated Agilent systems
• 2-minute analysis times for inorganic arsenic deliver 5x throughput vs conventional methods
• Detection limits well below regulatory action levels ensure compliance confidence
• Single software control reduces setup complexity and streamlines daily operation

🖥️ Watch the Detection of Microplastics using Thermoanalytical Methods webinar to learn about which analytical approach(es) offer the best results for PFAS in the environment.

The challenges of high-volume water testing during summer

🖥️ Watch the Analysis of PFAS: Strategies to Optimise Performance webinar to learn about which analytical approach(es) offer the best results for PFAS in the environment.

📚 Download the Guide to Targeted Quantification and Screening of PFAS Compounds in Environmental Matrices Primer to explore the basics and the regulatory framework for PFAS analysis.

Agilent water testing solutions: Speed, sensitivity, and scale

Key Agilent Instruments for Water Quality Testing

• Agilent Ultivo LC/MSMS – Ideal for ultra-trace PFAS and persistent organic pollutants in drinking and environmental water. Compact yet powerful, it supports high-throughput labs with limited space.
• Agilent 6475 LC/MSMS – Offers sensitive, reproducible quantification of a wide range of contaminants in complex matrices.
• Agilent 1290 Infinity III LC System – Delivers fast, reliable chromatographic separations critical to high-throughput analysis.
• Agilent 8860 GC and Agilent 5977B GC-MSD – Combines rugged GC performance with high-sensitivity mass detection, ideal for volatile organic compound analysis.
• InfinityLab PFC-Free HPLC Conversion Kit – Helps reduce PFAS background interference for cleaner data and better detection accuracy.

Keeping communities and holidaymakers safe

Ready to modernise your water testing workflows?

✅ TL;DR – Key Takeaways

• South Africa’s festive season significantly increases demand for water testing.
• Water contamination risks rise in both drinking supplies and recreational sources.
• Agilent offers a suite of instruments for rapid, high-sensitivity testing (LC/MS, GC/MS, HPLC).
• Automation-ready workflows improve throughput and reduce manual handling.
• Accurate testing ensures public health, supports tourism, and builds trust in infrastructure.

The complexities of testing diverse consumer products

How Agilent’s advanced analytical instruments support comprehensive testing

What challenges do manual workflows present during peak testing periods?

How can automation help labs overcome throughput bottlenecks?

Why is automation crucial for South Africa’s diverse testing requirements?

What are the specific benefits of Raykol’s automated SPE systems during festive peaks?

Raykol’s automated SPE systems

Ready to transform your lab’s festive season workflow?

✅ TL;DR – Key Takeaways

• December is the peak testing season for South African labs across multiple industries.
• Manual prep workflows cause delays, errors, and staff fatigue during high volumes.
• Automation with Raykol SPE systems accelerates prep, boosts throughput, and ensures consistent results.
• Lab automation frees scientists to focus on data interpretation and innovation.
• Essential for labs handling diverse testing needs to stay competitive and compliant.